RiKarbon, Inc. – Trademark Portfolio
Entity Type: 03
RiKarbon, Inc. owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as UPSYCAL, RIKARBON, and RIPURPOSE. Of these, 6 are registered. The portfolio spans 6 Nice Classification classes, led by Class 1 (Chemicals) and Class 42 (Computer & Scientific). Headquartered in Newark, DE.
550 S. College Avenue, Suite 107
Newark, DE 19713
Showing of trademarks Trademarks
Trademark Classifications
RiKarbon, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does RiKarbon, Inc. have?
RiKarbon, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does RiKarbon, Inc. file in?
RiKarbon, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 4 (Lubricants & Fuels), Class 17 (Rubber Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are RiKarbon, Inc.'s most well-known trademarks?
RiKarbon, Inc.'s registered trademark portfolio includes well-known marks such as UPSYCAL, RIKARBON, and RIPURPOSE. These are among 6 currently registered trademarks in the portfolio.
What is RiKarbon, Inc.'s trademark registration success rate?
RiKarbon, Inc. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.